http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
a companion to Braunwald's heart disease
1 online resource (xix, 584 pages) : illustrations
Dr. Ballantyne- one of the foremost lipid experts in the world and recruited by Dr. Braunwald's Heart Disease editorial team- together with a stellar cast of contributors provides all of the scientific and clinical information you need to effectively manage every aspect of dyslipidemia. From basic science to pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options, this new title in the Braunwald's Heart Disease family offers unparalleled up-to-date coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style. Plus, Expert Consult functionality gives you anytime, anywhere access to the full text online. Includes full text online access at expertconsult.com. Features the expertise of one of the foremost experts in the field, ensuring you get authoritative guidance with the most definitive knowledge available. Contains extensive clinically relevant information covering risk assessment, therapy, special patient populations, and experimental therapies, including targeting HDL to help you effectively manage any challenges you face. Uses treatment algorithms for easy access to key content. Presents current practice guidelines that assist in the decision-making process.
Human Plasma Lipoprotein Metabolism -- Regulation and Clearance of Apolipoprotein B-Containing Lipoproteins -- Absorption and Excretion of Cholesterol and Other Sterols -- High-Density Lipoprotein Metabolism -- Lipoproteins: Mechanisms for Atherogenesis and Progression of Atherothrombotic Disease -- Genetic Dyslipidemia -- High-Density Lipoprotein Mutations -- Lipoprotein Oxidation and Modification -- Cholesterol: Concentration, Ratio, and Particle Number -- High-Density Lipoprotein Cholesterol in Coronary Heart Disease Risk Assessment -- Lipoprotein(a) -- Clinical Evaluation for Genetic and Secondary Causes of Dyslipidemia -- Use of High-Sensitivity C-Reactive Protein for Risk Assessment -- Role of Lipoprotein-Associated Phospholipase A2 in Vascular Disease -- Emerging Assays -- Noninvasive Assessments of Atherosclerosis for Risk Stratification -- Overview of General Approach to Management of Elevated Low-Density Lipoprotein Cholesterol and Mixed Dyslipidemia, High Triglycerides, and Low High-Density Lipoprotein Cholesterol -- Treatment Guidelines Overview -- Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease -- Exercise and Lipids -- Weight Loss -- Statins -- Bile Acid Sequestrants -- Cholesterol Absorption Inhibitors -- Nicotinic Acid -- Fibrates -- Omega-3 Fatty Acids -- Endocannabinoid Receptor Blockers -- Combination Therapy for Dyslipidemia -- Low-Density Lipoprotein Apheresis -- Nutriceuticals and Functional Foods for Cholesterol Reduction -- Evolving Targets of Therapy -- Modulation of Biomarkers of Inflammation -- Invasive Imaging Modalities and Atherosclerosis: The Role of Intravascular Ultrasound -- Noninvasive Imaging Modalities and Atherosclerosis: The Role of Ultrasound -- Noninvasive Imaging Modalities and Atherosclerosis: The Role of Magnetic Resonance Imaging and Positron Emission Tomography Imaging -- Special Patient Populations: Diabetes and Metabolic Syndrome -- Special Patient Populations: Women and Elderly -- Special Patient Populations: Acute Coronary Syndromes -- Special Patient Populations: Transplant Recipients -- Special Patient Populations: Chronic Renal Disease -- Special Patient Populations: Lipid Abnormalities in High-Risk Ethnic Groups -- Special Patient Populations: HIV Patients -- Investigational Agents Affecting Atherogenic Lipoproteins -- Therapeutic Targeting of High-Density Lipoprotein Metabolism -- Experimental Therapies of the Vessel Wall.
Includes bibliographical references and index.
Philadelphia, PA : Saunders/Elsevier, ©2009
139783:139920 Elsevier Science & Technology